Ascendant Diagnostics | Tear-Based Breast Cancer Diagnosis
Ascendant Dx is an early stage biotechnology company that was formed in September of 2010 with a focus on developing innovative new approaches to improve the diagnosis of serious disease and conditions.
Ascendant’s first product in development is an in vitro diagnostic assay to detect early stage breast cancer utilizing the proteomic profile present in tears. Implementation of our test in the market place will lead to greater rates of survivability by increasing early detection of breast cancer.
We believe our simple, non-invasive tear-based collection method will rapidly lead to increased participation by individuals who choose not to utilize currently available yearly screening methods.
- Life Sciences
- 535 W. Research Center Blvd.
- Fayetteville, AR 72701
- Omid Moghadam,
- Chief Executive Officer
- Anna Daily, PhD
- Senior Scientist
- Kimberley Fuller,
- Director of Market Research
- and Business Development
The Illumina laser projection system from Power Technology Inc. of Alexander represents a potential win-win for movie-goers and theater owners, and that double score was on full display Monday at the Ron Robinson Theater in Little Rock's River Market District.
In reality, innovative research with world-changing implications happens every day in our universities and private companies. But what good is the best research discovery, technology or innovation if it never leaves the lab?
Nancy Gray, the new director of UAMS BioVentures, has more than 30 years of experience in biomedical industries, including medicinal chemistry research, management of pharmaceutical research and development, and business operations.
Strong Suit Clothing LLC, which was formed a year ago, recently raised $1 million and will soon have its line in Nordstrom. It also plans to start its own e-commerce website that will be headed by the Arkansas online sales guru John James, a founder of Innovate Arkansas client firm Acumen Holdings of Fayetteville.